Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004304667 | SCV003965440 | uncertain significance | not specified | 2023-05-08 | criteria provided, single submitter | clinical testing | The c.1111G>T (p.V371F) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a G to T substitution at nucleotide position 1111, causing the valine (V) at amino acid position 371 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |